SE8401424D0 - Sett att bestemma immunkomplex specifika mot tumor-associerad antigen - Google Patents

Sett att bestemma immunkomplex specifika mot tumor-associerad antigen

Info

Publication number
SE8401424D0
SE8401424D0 SE8401424A SE8401424A SE8401424D0 SE 8401424 D0 SE8401424 D0 SE 8401424D0 SE 8401424 A SE8401424 A SE 8401424A SE 8401424 A SE8401424 A SE 8401424A SE 8401424 D0 SE8401424 D0 SE 8401424D0
Authority
SE
Sweden
Prior art keywords
complement
insolubilized
immune complex
associated antigen
tumor associated
Prior art date
Application number
SE8401424A
Other languages
English (en)
Other versions
SE467987B (sv
SE8401424L (sv
Inventor
M Ishii
S Akazawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8401424D0 publication Critical patent/SE8401424D0/sv
Publication of SE8401424L publication Critical patent/SE8401424L/sv
Publication of SE467987B publication Critical patent/SE467987B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8401424A 1982-07-16 1984-03-14 Saett att bestaemma maengden av ett tumoerantigen-immunokomplex SE467987B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12494582A JPS5915858A (ja) 1982-07-16 1982-07-16 腫瘍関連抗原特異的免疫複合体の測定法
PCT/JP1983/000228 WO1984000421A1 (en) 1982-07-16 1983-07-14 Method for assaying tumor-associated antigen-specific immune complex

Publications (3)

Publication Number Publication Date
SE8401424D0 true SE8401424D0 (sv) 1984-03-14
SE8401424L SE8401424L (sv) 1984-03-14
SE467987B SE467987B (sv) 1992-10-12

Family

ID=14898080

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401424A SE467987B (sv) 1982-07-16 1984-03-14 Saett att bestaemma maengden av ett tumoerantigen-immunokomplex

Country Status (7)

Country Link
EP (1) EP0100914B1 (sv)
JP (1) JPS5915858A (sv)
CH (1) CH662427A5 (sv)
DE (1) DE3367281D1 (sv)
GB (1) GB2133146B (sv)
SE (1) SE467987B (sv)
WO (1) WO1984000421A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685818T2 (de) * 1986-03-10 1993-01-14 Imre Corp Immunkomplextestverfahren.
US5179000A (en) * 1987-07-24 1993-01-12 Nippon Kayaku Kabushiki Kaisha Method for assaying basic fetoprotein in urine and assay kit therefor
WO1991006866A2 (en) * 1989-11-03 1991-05-16 Morton Donald L Urinary tumor associated antigen, antigenic subunits uses and methods of detection
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
US5840317A (en) * 1989-11-03 1998-11-24 Morton; Donald L. Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
RO114835B1 (ro) * 1997-03-17 1999-07-30 Ioan Puşcaş Metodă rapidă de diagnostic al cancerelor
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590524A (en) * 1976-11-24 1981-06-03 Nat Res Dev Assay of immune complexes
ES471585A1 (es) * 1977-07-15 1979-01-16 Behringwerke Ag Procedimiento para la determinacion de reactivos fc
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
CA1166957A (en) * 1980-05-08 1984-05-08 Barry I. Bluestein Immunoassay for oncofetal antigen carried by lymphocytes
WO1982000525A1 (en) * 1980-07-25 1982-02-18 Otsuka Pharma Co Ltd Method for determining tumor-associated glucose side chain,method for diagnosing tumors,and kit for diagnosing tumors
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
JPS5729951A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determintion of sugar side chain related to cancer
JPS5729950A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination method of sugar side chain related to cancer
US4548909A (en) * 1980-10-24 1985-10-22 David Parratt Method of diagnosis

Also Published As

Publication number Publication date
DE3367281D1 (en) 1986-12-04
WO1984000421A1 (en) 1984-02-02
JPS5915858A (ja) 1984-01-26
SE467987B (sv) 1992-10-12
EP0100914B1 (en) 1986-10-29
GB2133146B (en) 1986-01-08
GB8403775D0 (en) 1984-03-21
GB2133146A (en) 1984-07-18
CH662427A5 (de) 1987-09-30
SE8401424L (sv) 1984-03-14
EP0100914A1 (en) 1984-02-22

Similar Documents

Publication Publication Date Title
SE8205751D0 (sv) Device and method for determining the presence of antigens
EP0089008A3 (en) Method for the combined immunological determination of procollagen peptide (type iii) and procollagen peptide col 1 (type iii), and method for the production of anti-procollagen peptide col 1 (type iii) serum
SE8200978L (sv) Forfarande och medel for immunologisk analys
ES8206856A1 (es) Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica
ATE143052T1 (de) Chimärisches murine-mensch-immunoglobulin, spezifisch für tumorassoziertes 17-1a antigen
EP0098162A3 (en) Monoclonal antibodies specific to carcinoembryonic antigen
DE3574184D1 (en) Support material for the use in immunoassays
EP0292810A3 (en) One-step immunoassay for the determination of antigen-specific antibodies from one of the immunoglobulin classes a,m,d or e and reagent therefor
SE8006424L (sv) Sett att bestemma ett antigen i losning
NL181461C (nl) Werkwijze en reagenskit voor het bepalen van antigenen, antilichamen of antigeen-antilichaam-complexen of -conjugaten.
SE8401424D0 (sv) Sett att bestemma immunkomplex specifika mot tumor-associerad antigen
DE3361048D1 (en) Immunological latex-agglutination process
ES484166A1 (es) Procedimiento para la deteccion y determinacion de un anti- cuerpo fijador del complemento
EP0171083A3 (en) Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
DK157109C (da) Immunokemisk reagens
EP0554657A3 (en) Method for the determination of antigens or antibodies in the presence of an immune complex
EP0313986A3 (en) Immunoassays using antigens produced in heterologous organisms
EP0158291A3 (en) A method for purifying carcinoembryonic antigen and a method for producing a carcinoembryonic antigen-reactive monoclonal antibody
GB2203836A (en) Determination of analyte concentration
DE3476458D1 (en) Immunoassay for the determination of antibodies against native dna
FI91976C (sv) Förfarande och reagens för bestämning av ett follikelstimulerande hormon samt härför lämpliga monoklonala antikroppar
SE8601645D0 (sv) Immunologiskt forfarande
EP0389929A3 (en) Method for determining cell surface antigen in complexed antigen-antibody reaction system and immunocyte-fixation apparatus used in said method

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401424-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8401424-0

Format of ref document f/p: F